|
|
Article: Appointments And Advancements.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Amylin Pharmaceuticals Inc., of San Diego, promoted Daniel Bradbury to president and chief operating officer, and to its board.
Archemix Corp., of Cambridge, Mass., appointed John Maraganore to its board.
Aspreva Pharmaceuticals Corp., of Victoria, British Columbia, appointed William Hunter to its board.
AtheroGenics Inc., of Atlanta, appointed Brian Blakey vice president of marketing.
BioSyntech Inc., of Laval, Quebec, appointed Rudy Huber and Joyce Tsang to its board.
Cardiome Pharma Corp., of Vancouver, British Columbia, appointed Curtis Sikorsky chief financial officer.
Cardium Therapeutics Inc., of San Diego, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Genentech appoints John Mclaughlin as vice ...
PR Newswire;
February 23, 1989 ;
565 words
... ... APPOINTS JOHN MCLAUGHLIN AS VICE PRESIDENT - GENERAL COUNSEL SOUTH SAN FRANCISCO, Calif., Feb ... John P. McLaughlin as vice president - general counsel. McLaughlin ... previously was Genentech's vice president of government affairs ...
|
|